CJC-1295

CJC-1295 is a synthetic tetrasubstituted peptide analogue of growth hormone-releasing hormone (GHRH) currently being investigated in scientific research for its potential role in endocrine function and somatotropic axis stimulation. As a modified GHRH derivative designed to extend plasma half-life through albumin binding, it has attracted significant interest in preclinical studies exploring sustained growth hormone release.

Current laboratory research is investigating CJC-1295 for its potential involvement in:

• Growth hormone-releasing hormone (GHRH) receptor agonist studies

• Endocrine signaling pathway and pulsatile GH release research

• Plasma half-life extension and Drug Affinity Complex (DAC) technology investigations

• Downstream insulin-like growth factor-1 (IGF-1) elevation studies

• Pituitary somatotroph response research

• Metabolic regulation and protein synthesis pathway research

Product Specifications

• Product: CJC-1295

• Quantity: 5 mg

• Form: Lyophilized Powder

• Purity: Research Grade

• Storage: Store refrigerated at 2–8°C. For long-term storage, keep frozen at -20°C.

Research Use Only
This product is intended for laboratory and scientific research purposes only.
Not for human or veterinary use.
This product is not intended to diagnose, treat, cure, or prevent any disease and must only be handled by qualified research professionals.